Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the international TriValve registry

…, U Schäfer, J Schofer, H Sievert, K Sievert… - JACC: Cardiovascular …, 2019 - jacc.org
Objectives : A large, prospective international registry was developed to evaluate the initial
clinical applications of transcatheter tricuspid valve intervention (TTVI) with different devices. …

Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction

…, N Piazza, H Alosaimi, H Sievert, K Sievert… - Journal of the American …, 2020 - jacc.org
Background Transcatheter aortic valve replacement (TAVR) use is increasing in patients
with longer life expectancy, yet robust data on the durability of transcatheter heart valves (THVs) …

Transcatheter replacement of transcatheter versus surgically implanted aortic valve bioprostheses

…, N Piazza, H Alosaimi, H Sievert, K Sievert… - Journal of the American …, 2021 - jacc.org
Background Surgical aortic valve replacement and transcatheter aortic valve replacement (TAVR)
are now both used to treat aortic stenosis in patients in whom life expectancy may …

Measurement of myofilament-localized calcium dynamics in adult cardiomyocytes and the effect of hypertrophic cardiomyopathy mutations

AJ Sparrow, K Sievert, S Patel, YF Chang… - Circulation …, 2019 - Am Heart Assoc
Rationale: Subcellular Ca 2+ indicators have yet to be developed for the myofilament where
disease mutation or small molecules may alter contractility through myofilament Ca 2+ …

Transvenous right greater splanchnic nerve ablation in heart failure and preserved ejection fraction: first-in-human study

…, G Shaishmelashvili, H Sievert, K Sievert… - Heart Failure, 2022 - jacc.org
Background Ablation of the right-sided greater splanchnic nerve (GSN) can reduce excessive
splanchnic vasoconstriction, potentially improving the handling of volume shifts in patients …

Transcatheter treatment of residual significant mitral regurgitation following TAVR: a multicenter registry

…, R Valvo, O De Backer, JF Ooms, K Sievert… - Cardiovascular …, 2020 - jacc.org
Objectives The aim of this study was to describe baseline characteristics, and periprocedural
and mid-term outcomes of patients undergoing transcatheter mitral valve interventions post-…

Prevalence of the metabolic syndrome among extremely obese adolescents in Italy and Germany

…, F Adorni, F Agosti, A De Col, K Sievert… - Diabetes research and …, 2010 - Elsevier
Juvenile metabolic syndrome (MetS) is a growing major medical problem in industrialised
countries. We estimated its prevalence among two similar clinic-based sequentially recruited …

Left atrial appendage occlusion with lambre in atrial fibrillation: initial European experience

JW Park, H Sievert, C Kleinecke, L Vaskelyte… - International Journal of …, 2018 - Elsevier
Background We here report the first European experience with the novel LAmbre left atrial
appendage (LAA) occluder, a self-expanding device consisting of an umbrella and a cover …

Acute stroke interventions performed by cardiologists: initial experience in a single center

M Hornung, SC Bertog, I Grunwald, K Sievert… - JACC: Cardiovascular …, 2019 - jacc.org
Objectives : The aim of this study was to evaluate the technical and clinical success of acute
stroke interventions performed in our interventional cardiology center. Background : …

Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN

J Ledwoch, K Sievert, LVA Boersma… - EP …, 2020 - academic.oup.com
Aims Evidence regarding post-procedural antithrombotic regimen other than used in
randomized trials assessing percutaneous left atrial appendage (LAA) closure is limited. The …